Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott D Solomon

Showing results (571-580 of 1,211) with videos related to

Pageof 122
Sort By:
European Journal of Heart Failure|April 2, 2010
Baseline characteristics and outcomes of patients with heart failure receiving bronchodilators in the CHARM programmeNathaniel M Hawkins, Duolao Wang, Mark C Petrie, et al.
JAMA Cardiology|April 5, 2018
Effects of Sacubitril/Valsartan on Physical and Social Activity Limitations in Patients With Heart Failure: A Secondary Analysis of the PARADIGM-HF TrialAlvin Chandra, Eldrin F Lewis, Brian L Claggett, et al.
American Heart Journal|December 6, 2011
Rationale and design of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial: a randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fractionAkshay S Desai, Eldrin F Lewis, Rebecca Li, et al.
European Heart Journal|June 29, 2025
Vaccination as a new form of cardiovascular prevention: a European Society of Cardiology clinical consensus statementBettina Heidecker, Peter Libby, Vassilios S Vassiliou, et al.
Journal of the American Heart Association|January 21, 2015
Beat-to-beat spatiotemporal variability in the T vector is associated with sudden cardiac death in participants without left ventricular hypertrophy: the Atherosclerosis Risk in Communities (ARIC) StudyJonathan W Waks, Elsayed Z Soliman, Charles A Henrikson, et al.
JAMA Cardiology|March 17, 2019
Association of Patisiran, an RNA Interference Therapeutic, With Regional Left Ventricular Myocardial Strain in Hereditary Transthyretin Amyloidosis: The APOLLO StudyMasatoshi Minamisawa, Brian Claggett, David Adams, et al.
Circulation. Heart Failure|October 8, 2009
Predictors of heart failure in patients with stable coronary artery disease: a PEACE studyEldrin F Lewis, Scott D Solomon, Kathleen A Jablonski, et al.
European Journal of Heart Failure|May 23, 2012
Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN TrialTomasz Siminiak, Justina C Wu, Michael Haude, et al.
JACC. Heart Failure|November 15, 2020
Atrial Natriuretic Peptide and Treatment With Sacubitril/Valsartan in Heart Failure With Reduced Ejection FractionSean P Murphy, Margaret F Prescott, Alexander Camacho, et al.
Journal of the American College of Cardiology|March 21, 2020
Systolic Blood Pressure in Heart Failure With Preserved Ejection Fraction Treated With Sacubitril/ValsartanSenthil Selvaraj, Brian L Claggett, Michael Böhm, et al.
Pageof 122

Showing results (571-580 of 1,211) with videos related to

Sort By:
Pageof 122
European Journal of Heart Failure|April 2, 2010
Baseline characteristics and outcomes of patients with heart failure receiving bronchodilators in the CHARM programmeNathaniel M Hawkins, Duolao Wang, Mark C Petrie, et al.
JAMA Cardiology|April 5, 2018
Effects of Sacubitril/Valsartan on Physical and Social Activity Limitations in Patients With Heart Failure: A Secondary Analysis of the PARADIGM-HF TrialAlvin Chandra, Eldrin F Lewis, Brian L Claggett, et al.
American Heart Journal|December 6, 2011
Rationale and design of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial: a randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fractionAkshay S Desai, Eldrin F Lewis, Rebecca Li, et al.
European Heart Journal|June 29, 2025
Vaccination as a new form of cardiovascular prevention: a European Society of Cardiology clinical consensus statementBettina Heidecker, Peter Libby, Vassilios S Vassiliou, et al.
Journal of the American Heart Association|January 21, 2015
Beat-to-beat spatiotemporal variability in the T vector is associated with sudden cardiac death in participants without left ventricular hypertrophy: the Atherosclerosis Risk in Communities (ARIC) StudyJonathan W Waks, Elsayed Z Soliman, Charles A Henrikson, et al.
JAMA Cardiology|March 17, 2019
Association of Patisiran, an RNA Interference Therapeutic, With Regional Left Ventricular Myocardial Strain in Hereditary Transthyretin Amyloidosis: The APOLLO StudyMasatoshi Minamisawa, Brian Claggett, David Adams, et al.
Circulation. Heart Failure|October 8, 2009
Predictors of heart failure in patients with stable coronary artery disease: a PEACE studyEldrin F Lewis, Scott D Solomon, Kathleen A Jablonski, et al.
European Journal of Heart Failure|May 23, 2012
Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN TrialTomasz Siminiak, Justina C Wu, Michael Haude, et al.
JACC. Heart Failure|November 15, 2020
Atrial Natriuretic Peptide and Treatment With Sacubitril/Valsartan in Heart Failure With Reduced Ejection FractionSean P Murphy, Margaret F Prescott, Alexander Camacho, et al.
Journal of the American College of Cardiology|March 21, 2020
Systolic Blood Pressure in Heart Failure With Preserved Ejection Fraction Treated With Sacubitril/ValsartanSenthil Selvaraj, Brian L Claggett, Michael Böhm, et al.
Pageof 122